Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
61.17
+0.32 (0.53%)
Oct 28, 2025, 12:09 PM EDT - Market open

Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 18 analysts that cover Kymera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $65.56, which forecasts a 7.18% increase in the stock price over the next year. The lowest target is $52 and the highest is $81.

Price Target: $65.56 (+7.18%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$52$65.56$64$81
Change-14.99%+7.18%+4.63%+32.42%

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy677789
Buy677789
Hold422210
Sell000000
Strong Sell000000
Total161616161718

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Maintains
$59$75
Strong BuyMaintains$59$75+22.61%Oct 22, 2025
Mizuho
Mizuho
Buy
Initiates
$81
BuyInitiates$81+32.42%Oct 21, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$60$80
Strong BuyMaintains$60$80+30.78%Oct 17, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$53$63
BuyMaintains$53$63+2.99%Oct 1, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$53$68
Strong BuyMaintains$53$68+11.17%Sep 30, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
75.73M
from 47.07M
Increased by 60.88%
Revenue Next Year
59.88M
from 75.73M
Decreased by -20.93%
EPS This Year
-3.47
from -2.98
EPS Next Year
-4.09
from -3.47
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
34.03M72.83M46.83M78.59M47.07M75.73M59.88M
Revenue Growth
1,059.99%114.00%-35.71%67.84%-40.11%60.88%-20.93%
EPS
-3.15-2.09-2.87-2.52-2.98-3.47-4.09
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2425
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High154.3M141.8M
Avg75.7M59.9M
Low42.7Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
227.9%
87.2%
Avg
60.9%
-20.9%
Low
-9.2%
-

EPS Forecast

EPS20252026202720282029
High-2.60-2.78
Avg-3.47-4.09
Low-3.84-6.20

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.